REGULATORY

• Japan to Boost Screening of Coronavirus Variants: Minister
  March 19, 2021

• Japan IP High Court Snubs Ex-Grad Student's Appeal over Opdivo Patent Claim
  March 19, 2021

• Monitoring Panel to Require MHLW's Periodic Reports on Products Designated for Sakigake Review, Conditional Early Approval
  March 18, 2021

• MHLW to Continue Looking into Cause of Generic Scandals: Minister
  March 17, 2021

• All Municipalities to Get 2nd Doses for HCPs by Week of May 10: Minister
  March 15, 2021

• No Significant Concerns Observed with Pfizer COVID-19 Vaccine: Japan Safety Panels
  March 15, 2021

• Site Pain Common with COVID-19 Vaccine, but It Improves in 3 Days: Safety Follow-Up
  March 15, 2021

• MHLW Don’t Rule Out 7 Doses per Vial, but Won’t Recommend It for Pfizer Vaccine: Minister
  March 15, 2021

• MHLW Panel Determines Medical Need for 4 Drugs Including Acetaminophen
  March 15, 2021

• Olumiant, 7 More APIs Earn Orphan Designation: MHLW
  March 12, 2021

• 2nd-Dose Shot Starts for COVID-19 Vaccination in Japan
  March 12, 2021

• AMED to Fund 22 More Projects to Develop COVID-19 Treatments
  March 11, 2021

• Govt Won’t Widely Recommend Use of 7-Dose Syringes for Pfizer Vaccine: Top Spokesman
  March 10, 2021

• Medical Institutions Would Be Allowed to Provide 7 Doses per Vial of Pfizer’s COVID-19 Vaccine: Health Minister
  March 10, 2021

• PMDA to Launch Working Group in April to Step Up Use of RWD
  March 10, 2021

• Japan to Consider Ways to Speed Up Ivermectin Research for COVID-19
  March 9, 2021

• Imfinzi, 2 Other Drugs under PMDA Safety Review
  March 8, 2021

• Japan Speeds Up Vaccine Delivery for HCPs, Kono Says All 2nd Doses to Reach Municipalities in 1st Half of May
  March 8, 2021

• MHLW Presents Views on “Pharma Industry Vision 2021” to LDP’s Project Team
  March 8, 2021

• Japan Confirms 1st Case of Anaphylaxis from COVID-19 Vaccination
  March 8, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• …
• Next ›
• 最終 »